Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d

Colin Young, Olamide Oladipo, Samuel Frasier, Robert Putko, Stacy Chronister, Mary Marovich

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A 26-year-old male was presented to a military treatment facility in Afghanistan shortly after taking a weight-lifting supplement called Jack3d with a severe headache and was subsequently found to have suffered a Dejerine-Roussy variant right thalamic hemorrhagic stroke. Jack3d active ingredients include geranamine, schizandrol A, caffeine, β-alanine, creatine monohydrate, and L-arginine α-ketoglutarate. A literature search revealed case reports suggesting some of the constituent ingredients may predispose to stroke and hemorrhage and also revealed a substantial paucity of data existed regarding schizandrol A, a herb used in traditional eastern medicine. The product has no readily apparent disclaimer or warning regarding the risks or lack of data regarding the components. Jack3d is sold as a nutritional supplement and is therefore not subject to same FDA regulation and scrutiny that a pharmaceutical receives. The potential adverse effect was reported to the FDA via MedWatch in accordance with the recently passed Dietary Supplement and Nonprescription Drug Consumer Protection Act.

Original languageEnglish
Pages (from-to)1450-1454
Number of pages5
JournalMilitary Medicine
Volume177
Issue number12
DOIs
StatePublished - 1 Dec 2012

Fingerprint

Sports
Military Facilities
Stroke
Weight Lifting
Nonprescription Drugs
Afghanistan
Creatine
Traditional Medicine
Dietary Supplements
Caffeine
Alanine
Headache
Arginine
Hemorrhage
Pharmaceutical Preparations
schizandrin
Therapeutics

Cite this

Young, Colin ; Oladipo, Olamide ; Frasier, Samuel ; Putko, Robert ; Chronister, Stacy ; Marovich, Mary. / Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. In: Military Medicine. 2012 ; Vol. 177, No. 12. pp. 1450-1454.
@article{64b8f4f1b03b41c8a777a76e8e181bbb,
title = "Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d",
abstract = "A 26-year-old male was presented to a military treatment facility in Afghanistan shortly after taking a weight-lifting supplement called Jack3d with a severe headache and was subsequently found to have suffered a Dejerine-Roussy variant right thalamic hemorrhagic stroke. Jack3d active ingredients include geranamine, schizandrol A, caffeine, β-alanine, creatine monohydrate, and L-arginine α-ketoglutarate. A literature search revealed case reports suggesting some of the constituent ingredients may predispose to stroke and hemorrhage and also revealed a substantial paucity of data existed regarding schizandrol A, a herb used in traditional eastern medicine. The product has no readily apparent disclaimer or warning regarding the risks or lack of data regarding the components. Jack3d is sold as a nutritional supplement and is therefore not subject to same FDA regulation and scrutiny that a pharmaceutical receives. The potential adverse effect was reported to the FDA via MedWatch in accordance with the recently passed Dietary Supplement and Nonprescription Drug Consumer Protection Act.",
author = "Colin Young and Olamide Oladipo and Samuel Frasier and Robert Putko and Stacy Chronister and Mary Marovich",
year = "2012",
month = "12",
day = "1",
doi = "10.7205/MILMED-D-11-00342",
language = "English",
volume = "177",
pages = "1450--1454",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "12",

}

Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. / Young, Colin; Oladipo, Olamide; Frasier, Samuel; Putko, Robert; Chronister, Stacy; Marovich, Mary.

In: Military Medicine, Vol. 177, No. 12, 01.12.2012, p. 1450-1454.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d

AU - Young, Colin

AU - Oladipo, Olamide

AU - Frasier, Samuel

AU - Putko, Robert

AU - Chronister, Stacy

AU - Marovich, Mary

PY - 2012/12/1

Y1 - 2012/12/1

N2 - A 26-year-old male was presented to a military treatment facility in Afghanistan shortly after taking a weight-lifting supplement called Jack3d with a severe headache and was subsequently found to have suffered a Dejerine-Roussy variant right thalamic hemorrhagic stroke. Jack3d active ingredients include geranamine, schizandrol A, caffeine, β-alanine, creatine monohydrate, and L-arginine α-ketoglutarate. A literature search revealed case reports suggesting some of the constituent ingredients may predispose to stroke and hemorrhage and also revealed a substantial paucity of data existed regarding schizandrol A, a herb used in traditional eastern medicine. The product has no readily apparent disclaimer or warning regarding the risks or lack of data regarding the components. Jack3d is sold as a nutritional supplement and is therefore not subject to same FDA regulation and scrutiny that a pharmaceutical receives. The potential adverse effect was reported to the FDA via MedWatch in accordance with the recently passed Dietary Supplement and Nonprescription Drug Consumer Protection Act.

AB - A 26-year-old male was presented to a military treatment facility in Afghanistan shortly after taking a weight-lifting supplement called Jack3d with a severe headache and was subsequently found to have suffered a Dejerine-Roussy variant right thalamic hemorrhagic stroke. Jack3d active ingredients include geranamine, schizandrol A, caffeine, β-alanine, creatine monohydrate, and L-arginine α-ketoglutarate. A literature search revealed case reports suggesting some of the constituent ingredients may predispose to stroke and hemorrhage and also revealed a substantial paucity of data existed regarding schizandrol A, a herb used in traditional eastern medicine. The product has no readily apparent disclaimer or warning regarding the risks or lack of data regarding the components. Jack3d is sold as a nutritional supplement and is therefore not subject to same FDA regulation and scrutiny that a pharmaceutical receives. The potential adverse effect was reported to the FDA via MedWatch in accordance with the recently passed Dietary Supplement and Nonprescription Drug Consumer Protection Act.

UR - http://www.scopus.com/inward/record.url?scp=84871408201&partnerID=8YFLogxK

U2 - 10.7205/MILMED-D-11-00342

DO - 10.7205/MILMED-D-11-00342

M3 - Article

C2 - 23397687

AN - SCOPUS:84871408201

VL - 177

SP - 1450

EP - 1454

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 12

ER -